Amphastar Pharmaceuticals (AMPH) Other financing activities (2013 - 2025)

Amphastar Pharmaceuticals' Other financing activities history runs 9 years deep, the most recent figure standing at $8000.0 for Q4 2025.

• In Q4 2025, Other financing activities rose 136.36% year-over-year to $8000.0; the TTM figure through Dec 2025 stood at $687000.0 (down 15.81% YoY), while the FY2025 annual figure was $687000.0, down 15.81% from the prior year.
• Other financing activities was $8000.0 for Q4 2025 at Amphastar Pharmaceuticals, up from $4000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $10.4 million in Q3 2023 to a low of -$22000.0 in Q4 2024.
• Historically, Other financing activities has averaged $876466.7 across 5 years, with a median of $252000.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Other financing activities plunged 104.49% in 2024, then soared 25400.0% in 2025.
• A 5-year view of Other financing activities shows it stood at $308000.0 in 2021, then tumbled by 99.03% to $3000.0 in 2022, then soared by 16233.33% to $490000.0 in 2023, then slumped by 104.49% to -$22000.0 in 2024, then soared by 136.36% to $8000.0 in 2025.
• The last three Other financing activities figures came in at $8000.0 (Q4 2025), $4000.0 (Q3 2025), and $253000.0 (Q2 2025), per Business Quant data.